Why the study?
Does aggressive statin and dual antiplatelet therapy reduce atheroma volume in a patient with unstable mobile thrombus aortic atheroma?
Does aggressive statin and dual antiplatelet therapy reduce atheroma volume in a patient with unstable mobile thrombus aortic atheroma?
Aggressive high-dose statin and dual antiplatelet therapy may rapidly stabilize and resolve complex, unstable aortic atheromas.
Answers are grounded in this paper and cite their sources.
May support rapid stabilization of unstable aortic atheroma with high-dose statin plus DAPT; hypothesis-generating and requires prospective confirmation.
We describe a case report that documented the efficacy and safety of medical therapy in stabilizing and resolving a complex and unstable aortic atheroma after a relatively short period. The patient had a large protruding, mobile, calcified nonulcerated atheroma involving the descending aorta and was therefore treated with aggressive combination therapy with high statin dosages (atorvastatin = 80 mg) and dual antiplatelet treatment (clopidogrel = 75 mg and aspirin = 100 mg). At follow-up, the echocardiogram showed a significant regression in the atheroma volume, with no signs suggestive of ulceration on its surface with the complete mobile component resolution.
No takes yet. Share an insight, caveat, or question.
D'Aloia et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: